# RTMS for the Treatment of Post-COVID Associated Affective Symptoms

> **NCT06716996** · NA · RECRUITING · sponsor: **Flurin Cathomas** · enrollment: 52 (estimated)

## Conditions studied

- Post COVID -19 Depression

## Interventions

- **DEVICE:** repeated transcranial magnetic stimulation
- **DEVICE:** sham treatment

## Key facts

- **NCT ID:** NCT06716996
- **Lead sponsor:** Flurin Cathomas
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-11-14
- **Primary completion:** 2027-10-31
- **Final completion:** 2028-10-31
- **Target enrollment:** 52 (ESTIMATED)
- **Last updated:** 2024-12-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06716996

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06716996, "RTMS for the Treatment of Post-COVID Associated Affective Symptoms". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT06716996. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*